ArticleFrontiers in cell and developmental biology2025
MSLI-Net: retinal disease detection network based on multi-segment localization and multi-scale interaction.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A gated task-attentive multi-task network for unified retinal image analysis.Scientific reports · 2026Article
- VEA-net: vascular enhancement attention with dual-backbone multi-task learning for comprehensive ROP management across multi-center datasets.Frontiers in cell and developmental biology · 2026Article
- Enhanced MRI brain tumor detection using deep learning in conjunction with explainable AI SHAP based diverse and multi feature analysis.Scientific reports · 2025Article
- HyReti-Net: hybrid retinal diseases classification and diagnosis network using optical coherence tomography.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The retina plays a critical role in visual perception, yet lesions affecting it can lead to severe and irreversible visual impairment. Consequently, early diagnosis and precise identification of these retinal lesions are essential for slowing disease progression. Optical coherence tomography (OCT) stands out as a pivotal imaging modality in ophthalmology due to its exceptional performance, while the inherent complexity of retinal structures and significant noise interference present substantial challenges for both manual interpretation and AI-assisted diagnosis. Methods: We propose MSLI-Net, a novel framework built upon the ResNet50 backbone, which enhances the global receptive field via a multi-scale dilation fusion module (MDF) to better capture long-range dependencies. Additionally, a multi-segmented lesion localization module (LLM) is integrated within each branch of a modified feature pyramid network (FPN) to effectively extract critical features while suppressing background noise through parallel branch refinement, and a wavelet subband spatial attention module (WSSA) is designed to significantly improve the model's overall performance in noise suppression by collaboratively processing and exchanging information between the low- and high-frequency subbands extracted through wavelet decomposition. Results: Experimental evaluation on the OCT-C8 dataset demonstrates that MSLI-Net achieves 96.72% accuracy in retinopathy classification, underscoring its strong discriminative performance and promising potential for clinical application. Conclusion: This model provides new research ideas for the early diagnosis of retinal diseases and helps drive the development of future high-precision medical imaging-assisted diagnostic systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.